Using psilocybin to help cancer patients with anxiety and depression
Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress
['FUNDING_R01'] · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · NIH-10903758
This study is looking at how psilocybin therapy might help people with advanced cancer feel less anxious and depressed, so they can enjoy a better quality of life while dealing with their illness.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEW YORK UNIVERSITY SCHOOL OF MEDICINE (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-10903758 on ClinicalTrials.gov |
What this research studies
This research investigates the use of psilocybin therapy to alleviate psychiatric distress in patients with advanced cancer. It aims to address significant anxiety and depression that many cancer patients experience, which can negatively impact their quality of life and treatment adherence. The approach involves administering psilocybin in a controlled therapeutic setting, where patients can engage in meaningful experiences that may lead to lasting improvements in their mental health and overall well-being. The study builds on previous findings that suggest psilocybin can produce positive changes in cognition and spirituality.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults with advanced cancer who are experiencing significant psychiatric distress, including anxiety and depression.
Not a fit: Patients who are not experiencing significant psychiatric distress or those with contraindications to psilocybin therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a novel therapeutic option for cancer patients suffering from severe anxiety and depression.
How similar studies have performed: Previous studies have shown promising results for psilocybin therapy in improving mental health outcomes in similar patient populations.
Where this research is happening
NEW YORK, UNITED STATES
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ROSS, STEPHEN — NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- Study coordinator: ROSS, STEPHEN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Adjustment Disorders, Advanced Cancer, Anxiety Disorders